SEC Form 4 · accession 0001623919-16-000057
EndoChoice Holdings, Inc. · GI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David N Gill
Officer — President and CFO
Period of report
Mar 29, 2016
Accepted (ET)
Mar 31, 2016 · 4:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001623919
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock, par value $0.001 per shareF1,F2 | Mar 29, 2016 | A | 14,826 | $0.00 | A | 137,405 | D | |
| Common stock, par value $0.001 per share | holding | — | — | — | 26,625 | I | By David N. Gill & Dianne P. Gill Joint Living Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F3 | $5.31 | Mar 29, 2016 | A | 32,230 | A | — | Mar 29, 2026 | Common stock, par value $0.001 per share | 32,230 | 32,230 | D |
Explanation of responses
- F1These shares represent an award of restricted stock units that will be settled in common stock upon vesting. The restricted stock units will vest over a four-year period with the first 25% vesting on March 29, 2017 and the remainder vesting ratably on the 29th of each month thereafter for a period of 36 months.
- F2The total direct shares shown includes 119,079 time-vesting restricted stock and/or unit award shares.
- F3This stock option will vest over a four-year period with the first 25% vesting on March 29, 2017 and the remainder vesting ratably on the 29th of each month thereafter for a period of 36 months.